Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.

Gadgeel SM, Ali S, Philip PA, Ahmed F, Wozniak A, Sarkar FH

Open source

DOI
10.1002/cncr.23100
Published
2007 Dec 15
Container
Cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.23100,
  title = {Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.},
  author = {Gadgeel SM and Ali S and Philip PA and Ahmed F and Wozniak A and Sarkar FH},
  year = {2007},
  journal = {Cancer},
  doi = {10.1002/cncr.23100},
  url = {https://doi.org/10.1002/cncr.23100}
}

RIS

TY  - JOUR
TI  - Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.
AU  - Gadgeel SM
AU  - Ali S
AU  - Philip PA
AU  - Ahmed F
AU  - Wozniak A
AU  - Sarkar FH
PY  - 2007
JO  - Cancer
DO  - 10.1002/cncr.23100
UR  - https://doi.org/10.1002/cncr.23100
ER  - 

APA

SM, G., S, A., PA, P., F, A., A, W., & FH, S. (2007). Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.. Cancer. https://doi.org/10.1002/cncr.23100

Source records